¼¡ÕóÂÎÐÔСÄÔЭµ÷²»ÄÜÑо¿½øÕ¹

À´Ô´£ºÑ°Ò½ÎÊÒ©Íø¡¡Ñ°Ò½ÎÊÒ©Íø

ÍÆ¼öÔĶÁ
     ¼¡ÕóÂÎÐÔСÄÔЭµ÷²»ÄÜ(dyssynergia cerebellaris myoclonica)ÊÇÒÔ¼¡ÕóÂΡ¢ñ²ðСÄÔÐÔ¹²¼Ãʧµ÷ÎªÌØÕ÷µÄÁÙ´²×ÛºÏÕ÷¡£ÓÖ³ÆRamsay Hunt×ÛºÏÕ÷(RHS)[1]¡£

    Ò»¡¢¶¨ÒåÓëÃüÃû

    1921ÄêHuntÔÚÌâΪ¡°¼¡ÕóÂÎÐÔСÄÔЭµ÷²»ÄÜ¡ª¡ªÔ­·¢ÐÔ³Ý×´ºËήËõ¡±µÄÎÄÕÂÖÐÃèÊö4ÀýÉ¢·¢²¡ÀýºÍ1¶ÔÂÏÉúÐֵܡ£Õâ¶ÔÂÏÉúÐÖµÜÓÚ¶ùͯÔçÆÚµÄ±íÏÖÀàËÆFriedreich¹²¼Ãʧµ÷£¬ÔÚ30Ëê×óÓÒ³öÏÖ¼¡ÕóÂκÍñ²ðÆäÖÐ1Àý36ËêËÀÍö£¬Ê¬¼ìÏÔʾ¼¹ËèСÄÔÊøºÍºóË÷±äÐÔ£¬³Ý×´ºËήËõ£¬Ð¡ÄÔÉϽűäϸ¡£Òò´Ë£¬HuntÈÏΪ¼¡ÕóÂκÍСÄÔÐÔ¹²¼Ãʧµ÷ÓÐÌØÊâµÄ¹ØÏµ£¬²¢ÍƶÏСÄÔ³Ý×´ºËϵͳµÄÔ­·¢ÐÔήËõÊǼ¡ÕóÂκÍСÄÔÐÔ¹²¼Ãʧµ÷µÄ²¡Àí»ù´¡£¬Ëæºó£¬ÒÔRamsay HuntÃüÃûµÄÐí¶àÏàËÆ²¡ÀýÒ²Ïà¼Ì±»±¨µÀ¡£È»¶ø£¬¹ØÓÚRHSÊÇ×÷Ϊһ¸ö¼²²¡µÄʵÌ壬»¹ÊÇÒ»¸ö×ÛºÏÕ÷£¬Ò»Ö±ÊǽüÆÚÕùÂ۵Ľ¹µã[2-6]£¬ÁÙ´²ÉÏÈËÃǺÜÄѽ«ÆäÓë½øÐÐÐÔ¼¡ÕóÂÎÐÔñ²ðï(progressive myoclonic epilepsy£¬ PME)ÖеÄÒ»ÖÖÀàÐÍ¡ª¡ªUnverrich-Lundborg²¡ÏàÇø·Ö£¬ËüÃÇÊÇ·ñÊôÓÚͬһÖÖ²¡Éв»Çå³þ¡£1990Ä꣬MarseilleЭ×÷С×齫RHS·Ö³ÉÁ½´óÀ࣬¼´PMEºÍ½øÐÐÐÔ¼¡ÕóÂÎÐÔ¹²¼Ãʧµ÷(progressive myoclonic ataxia£¬ PMA)[5£¬6]¡£PMEÊÇÖ¸¼¡ÕóÂΰéÓÐñ²ðï·¢×÷ºÍ½øÐÐÐÔÉñ¾­¹¦ÄÜË¥ÍË£¬ÈçÇá¶È¹²¼Ãʧµ÷ºÍ³Õ´ô¡£PMAÊÇÖ¸¼¡ÕóÂΡ¢½øÐÐÐÔСÄÔÐÔ¹²¼Ãʧµ÷£¬ñ²ðï·¢×÷²¢²»Æµ·±[6]¡£

    ¶þ¡¢²¡Àí¼°²¡ÀíÉúÀí

    ²¡Òò²»Ã÷£¬ÓëÒÅ´«Óйأ¬Hunt¶Ô1Àý¼¡ÕóÂΰéСÄÔÐÔ¹²¼Ãʧµ÷²¡È˽øÐÐʬ¼ìʱ·¢ÏÖСÄÔ³Ý×´ºËÔ­·¢ÐÔήËõ£¬Ð¡ÄÔÉϽűäϸ£»ÆäËûСÄԽṹ£¬Æ¤²ã¡¢éÏé­Ð¡ÄÔϵͳºÍÇÅÄÔСÄÔϵͳ¾ùÍêºÃ£¬×îÔçÌá³öСÄÔ³Ý×´ºË¼°´«³öϵͳÊǼ¡ÕóÂκÍСÄÔÐÔ¹²¼Ãʧµ÷µÄ²¡Àí»ù´¡[1£¬5]¡£1994Ä꣬KobayashiµÈ[7]µÄ1ÀýRHSʬ¼ì²¡Àí±¨µÀÏÔʾ¶îÒ¶°×ÖÊÍÑËèÇÊ¡¢Æ¤²ãÏÂÏËά½ºÖÊϸ°ûÏÔÖøÔöÉú£¬³Ý×´ºËºÍÏÂéÏ魺˳ÊÄý¿éÑù±äÐÔ£¬¹Ç÷À¼¡Ã»Óв»Õûºì±ßÏËά(RRF)£¬Ò²ÈÏΪ¼¡ÕóÂκ͹²¼Ãʧµ÷Óë³Ý×´ºËµÄÄý¿éÑù±äÐÔÃÜÇÐÏà¹Ø¡£ÐÂСÄԺͳÝ×´ºË´«³öϵͳÓë±£³ÖÖ«ÌåµÄ×ËÊÆ£¬ÓÈÆäÊǽü¶Ë¹Ø½Úͨ¹ýÔ¶¶ËÊÖÖ¸²Ù×÷À´µ÷Õû×ËÊÆÓйأ¬Òò¶ø¿ÉÒÔ˵Ã÷¼¡ÕóÂÎΪʲô·¢ÉúÓÚÌåλ±ä»¯ºÍÔ˶¯Ê±¡£Ò²ÓÐÈËÈÏΪ¼¡ÕóÂÎÊÇÓÉÓÚÓëÔ˶¯Óйصĸоõ(ÈçÉùÒô¡¢ÊÓ¾õºÍÇûÌå¸Ð¾õ)ÓÕ·¢Ô˶¯µÄÒ»ÖÖ¹ý¼¤·´Ó¦£¬Õý³£È˸оõ´«ÈëºÜ¿ì£¬¾­ÖÐÊàÉñ¾­ÏµÍ³´¦ÀíºóÒýÆð¼¡ÈâÐË·Ü£¬¶øÐ¡ÄԵĺËÍÅÊÇͨ¹ýÇðÄÔ¸¹Íâ²àºËÓëÆ¤²ãÁªÏµÀ´µ÷½ÚÔ˶¯£¬³Ý×´ºË²¡±äʹ¸Ð¾õ´«Èëµ½Ô˶¯Æ¤²ãÐ˷ܵÄʱ³ÌËõ¶Ì[8]¡£

    ÓÐÈË·¢ÏÖ£¬Ë𺦺ïµÄ³Ý×´ºË¼°Æä´«³öͨ·ʱ¿ÉµÃµ½ÓÉÆÆ»µ²¡ÔîÒýÆðµÄ¹²¼Ãʧµ÷ºÍÒâÏòÐÔÕð²ü£¬Óɴ̼¤²¡ÔîÒýÆðµÄÔ˶¯¹ý¶ÈºÍ¼¡ÕóÂΣ¬ÓÉÓÚ³Ý×´ºËÖеĸ÷¸öÇøÓò¿ÉÄÜÓë´óÄÔÆ¤²ã²»Í¬µÄÔ˶¯ÇøÓòÓÐÁªÏµ£¬Òò´Ë³Ý×´ºËµÄ²»Í¬ºËÍÅÊܵ½´Ì¼¤·ÅµçÒýÆð²»Í¬²¿Î»µÄ¼¡ÕóÂΣ¬¼¡ÕóÂβ¢²»ÊdzÝ×´ºËÑÏÖØµÄ¼±ÐÔËðº¦ËùÖ£¬¶øÊÇÂýÐԴ̼¤ËùÖ¡£

    Èý¡¢ÁÙ´²ÌØÕ÷

    RHS¶àÔÚ7¡«21Ëê·¢²¡£¬¿É·¢ÉúÓÚͬһ¼Ò×åÖУ¬ÄÐÅ®¾ù¿É·¢²¡£¬Îª³£È¾É«ÌåÏÔÐÔÒÅ´«ÍâÏÔ²»È«»ò³£È¾É«ÌåÒþÐÔÒÅ´«£¬¹ÊÉ¢·¢¾Ó¶à¡£Í»³ö±íÏÖΪ¶¯×÷ÐÔ¼¡ÕóÂΡ¢ñ²ðï·¢×÷ºÍСÄÔÐÔ¹²¼Ãʧµ÷¡£¼¡ÕóÂαíÏÖΪ¶ÌÔݵġ¢Í»·¢µÄ¡¢ÎÞ¹æÂÉÐԵļ¡ÈâÊÕËõ£¬¿ÉÒÔÊÇÈ«ÉíµÄ»ò¾ÖÏÞÓÚÒ»×é»ò¶à×鼡Ⱥ£¬ÎÞÒâʶɥʧ£¬¶ÔÔ˶¯¡¢¹â¡¢ÉùÒô´Ì¼¤ºÜÃô¸Ð£¬Ìåλ¸Ä±ä¡¢Ë¯ÃߺÍÇéÐ÷±ä»¯¾ù¿ÉʹÆä·¢×÷»ò¼ÓÖØ£¬¿ÉÄÜÊÇÓëÔ˶¯Óйصĸоõ´Ì¼¤µÄÒ»ÖÖ¹ý¼¤·´Ó¦£¬Å¼¶û¿ÉÒÔ³öÏÖÈ«ÉíǿֱÕóÂÎÐÔ·¢×÷£¬µ«²¢²»Æµ·±¡£¼¡ÕóÂγ£ºÍСÄÔÐÔ¹²¼Ãʧµ÷²¢´æ£¬±íÏÖΪ¹¹Òô²»Çå¡¢ÒâÏòÐÔÕð²ü¡¢±æ¾à²»Á¼µÈ£¬¹²¼Ãʧµ÷¿ÉÏÈÓ뼡ÕóÂλòÔÚ¼¡ÕóÂÎÊýÄêºó³öÏÖСÄÔÖ¢×´£¬ÔçÆÚ¿ÉÄÜÓÉÓÚСÄÔÖ¢×´½ÏÇá¶ø±»¼¡ÕóÂÎËùÑڸǡ£¶àÊýÎÞÖÇÄܼõÍË»òÇá¶ÈµÄÈÏÖªÕϰ­¡£±¾²¡½øÕ¹»ºÂý£¬²»Ó°ÏìÊÙÃü¡£

    ËÄ¡¢ÁÙ´²±íÏÖÀàËÆRHSµÄ¼²²¡

    ½Ï³£¼ûµÄÓУºUnverricht-Lundborg²¡(Òà³Æ²¨Â޵ĺ£¼¡ÕóÂÎ)£¬LaforaÌ岡£¬Éñ¾­ÔªÀ¯ÑùºÖÖ¬ÖʳÁ»ýÖ¢£¬ÏßÁ£ÌåÄÔ¼¡²¡MERRFÐÍ£¬Sialidosis²¡(Ó£ÌÒºì°ß¼¡ÕóÂÎ×ÛºÏÕ÷)[9]¡£

    ½ÏÉÙ¼ûµÄÓÐ:Gaucher²¡;GM2Éñ¾­½ÚÜÕÖ¬³Á»ýÖ¢£¬ÉúÎïËØ·´Ó¦ÐÔÄÔ²¡£¬Ô˶¯ÐÔ¼¡ÕóÂÎ-ÉöÔàËðº¦×ÛºÏÕ÷£¬³Ý×´ºËºìºË-²Ô°×ÇòÇðÄԵ׺ËήËõ£¬Ekbom×ÛºÏÕ÷(PME¡¢³Õ´ô¡¢Ö¬·¾Áö¡¢¹Ç÷À»ûÐÎ)£¬May-White×ÛºÏÕ÷(PME¡¢ÌýÁ¦É¥Ê§¡¢¹²¼Ãʧµ÷)µÈ¡£

    ËùÓÐÕâЩ¼²²¡¶¼ÓжÀÌØµÄÉú»¯¼°²¡Àí¸Ä±ä£¬Òà¾ßÓв»Í¬µÄÒÅ´«Ñ§ÌØÕ÷£¬ÈçÏßÁ£ÌåÄÔ¼¡²¡MERRFÐÍÊôĸϵÒÅ´«£¬ÓÉÓÚÏßÁ£ÌåµÄ½á¹¹ºÍ¹¦ÄÜÒì³£ËùÖ£¬¿É°éÓÐѪ¼°ÄÔ¼¹ÒºÈéËáºÍ±ûͪËáˮƽÔö¸ß£¬¼¡»î¼ì¿É¼ûRRFÏËά£¬Ä¿Ç°ÒÑÓÐÈË֤ʵÆä»ùÒòÍ»±äµÄλµãλÓÚÏßÁ£ÌåDNAµÄtRNALysA-G8344ÉÏ[9£¬10]¡£Unverricht-Lundborg²¡¼¡ÕóÂνÏÍ»³ö£¬Éú»¯¼°²¡ÀíÎÞÒì³££¬¶øLaforaÌ岡ÖÇÄܼõÍ˽ÏÃ÷ÏÔ£¬¼¡ÕóÂνÏÇᣬÄÔµçͼÏÔÊ¾ÌØÕ÷ÐÔÕíÒ¶ñ²ðﲨÊÍ·Å£¬ÄÔ¡¢¸Î¡¢¹Ç÷À¼¡¡¢Æ¤·ô»î¼ì¿É¼ûLaforaСÌ壬Éñ¾­ÔªÀ¯ÑùÖ¬ºÖÖʳÁ»ýÖ¢ÓëÖ¬·¾Ëá¹ýÑõ»¯Ã¸È±·¦Óйأ¬Sialidosis²¡µÄ²¡ÒòÊǦÁ-N-ÒÒõ£Éñ¾­°·Ã¸ºÍ¦Â-°ëÈéÌÇÜÕøȱ·¦£¬Gaucher²¡ÊÇÓÉÓÚÆÏÌÑÌÇÄÔÜÕøȱ·¦µÈËùÖ¡£ÓÉÓÚÉÏÊö¼²²¡¶¼¿ÉÒÔÒýÆð¼¡ÕóÂκ͹²¼Ãʧµ÷£¬ÁÙ´²ÉϺÜÄѽ«RHSÓëÉÏÊö¼²²¡Çø·Ö¿ªÀ´£¬ÌرðÊÇUnverricht-LundborgµÄÕï¶Ï±ê×¼[5](6¡«15ËêÆð²¡£¬±íÏÖ¼¡ÕóÂΡ¢Ç¿Ö±-ÕóÂη¢×÷¡¢ÌØÕ÷ÐÔÄÔµçͼ¸Ä±ä£¬³Ê½øÐÐÐÔ)ÓëRHS»ù±¾Ïàͬ¡£MarsdenµÈÑо¿ÁË30Àý¹ýÈ¥Õï¶ÏΪRHSµÄ²¡ÈË£¬¶ÔÆäÖÐ13Àý½øÐм¡»î¼ì£¬5Àý֤ʵΪÏßÁ£ÌåÄÔ¼¡²¡£¬¶øÏ൱һ²¿·ÖÈ˲¡Òò²»Ã÷£¬ÆäÖÐ4Àý·ûºÏUnverricht-LundborgµÄÕï¶Ï±ê×¼£¬¹ÊÎÒÃÇÈÏΪ£¬RHS²»ÄÜ×÷Ϊһ¸ö¶ÀÁ¢µÄ¼²²¡ÊµÌå´æÔÚ£¬¶øÊÇÒ»¸öÁÙ´²×ÛºÏÕ÷£¬¿ÉÒÔÓɶàÖÖÔ­ÒòÒýÆð£¬ÁÙ´²Ò½ÉúÒ²²»ÄܰÑRHS×÷Ϊ×îºóÕï¶Ï£¬¶øÓ¦´Ó¶à·½ÃæÅųöÉÏÊö¼²²¡¡£

    Îå¡¢µçÉúÀí¸Ä±ä

    ÄÔµçͼ¸Ä±äËäÎÞÌØÒìÐÔ£¬µ«ÄÔµçͼµÄÑо¿ÓÐÖúÓÚ½ÒʾRHSµÄ²¡±ä·¶Î§ºÍÀàÐÍ£¬ÄÔµçͼÉϿɼûµ½¹ã·º»òÉ¢Ôڵגּ¨¡¢¶à¼¬²¨¡¢¶à¼¬Âý²¨±©·¢£¬¶àΪ˫²à£¬¿É±»¹â´Ì¼¤ÓÕ·¢£¬RHS²»Í¬µÄÄÔµçͼ¸Ä±ä¿ÉÄÜ·´Ó³²»Í¬µÄ²¡Òò[8]¡£BergamasoµÈ·¢ÏÖ£¬RHS²¡È˵Ä˯Ãßʱ¿ìËÙÑÛ¶¯Ë¯ÃßÏûʧ£¬ËµÃ÷˯ÃßÖÜÆÚ±»ÆÆ»µ£¬²¢°éÈ«ÉíÐÔ¼¡ÕóÂη¢×÷£¬ÄÔµçͼÉÏ¿ìËÙÑÛ¶¯Ë¯Ã߽׶α»Õ󷢵גּ¨´úÌæ£¬¾­×µ¶¯Âö×¢ÉäÒìÎì°Í±ÈÍ׿ÉÔÝʱÒÖÖÆ¼¬²¨£¬±íÃ÷СÄÔºÍÄÔ¸ÉÔÚ¼²²¡µÄ·¢ÉúºÍ·¢Õ¹¹ý³ÌÖÐÆð×÷Óá£BenassiµÈ·¢ÏÖ¿ìËÙÑÛ¶¯Ë¯Ãß¡¢Ë¯Ãß²¨¡¢K-¸´ºÏ²¨ºÍ¸ß¼â²¨¾ù¼õÉÙ¡£¶øTassinariµÈ[11]·¢ÏÖ10ÀýRHS²¡È˵Ľá¹ûÈ´ÓëÖ®Ïà·´£¬ËùÓв¡È˵Ä˯ÃßÖÜÆÚ±£ÁôÍêºÃ¡£ÇåÐÑʱ¿É¼û4¡«5ÖÜÆÚ/ÃëµÄ¼¬²¨£¬¼¡ÕóÂη¢×÷ʱ¼¡µçͼ¿É¼û¼¡ÕóÂ⨣¬Í¬Ê±ÄÔµçͼÉÏÒ²¿É¼û¼¬²¨¡£KuneschµÈ¹Û²ì·¢ÏÖ£¬µ±RHS²¡ÈËÊÖÖ¸Êܵ½´Ì¼¤Ê±£¬ÔڸоõÔ˶¯Æ¤²ã¿É¼Ç¼µ½¾Þ´óµÄƤ²ãµç룬´ÓÊÖÖ¸Êܵ½´Ì¼¤ÖÁ¼¡ÕóÂγöÏÖµÄDZ·üÆÚÃ÷ÏÔÑÓ³¤¡£

    Áù¡¢ÁÙ´²Õï¶Ï

    RHSÕï¶ÏÖ÷ÒªÒÀ¿¿ÁÙ´²ÌØÕ÷£¬²¢ÇÒÅųýÓйؼ²²¡¡£Õï¶ÏÒªµã£º(1)7¡«21Ëê·¢²¡£¬ÓмÒ×åÒÅ´«Ê·£¬Ò²¿ÉÉ¢·¢£»(2)ÁÙ´²ÌØÕ÷:¼¡ÕóÂΡ¢Ð¡ÄÔÐÔ¹²¼Ãʧµ÷£¬¿É°éÓÐñ²ðï·¢×÷£¬µ«²»Æµ·±£»(3)ÄÔµçͼÏÔÊ¾ÌØÕ÷ÐԵגּ¨¡¢¶à¼¬²¨¡¢¼¬Âý²¨±©·¢¡£Ìå¸ÐÓÕ·¢µçλ¿É¼û¾Þ´óµÄƤ²ãµçλ£»(4)ÅųýÆäËû¼²²¡:ÏßÁ£ÌåÄÔ¼¡²¡¡¢Sialidosis²¡¡¢Éñ¾­½ÚÀ¯ÑùÖ¬ºÖÖʳÁ»ýÖ¢¡¢LaforeÌ岡¡¢Gaucher²¡µÈ¡£

    Æß¡¢ÖÎÁƼ°Ô¤ºó[12]

    ¶Ô±¾²¡µÄÖÎÁÆÖ÷ÒªÊÇÕë¶Ô¼¡ÕóÂΣ¬°²¶¨ÀàºÍ±ûÎìËáÄÆÊÇ×îÓÐЧµÄÒ©ÎÂÈÏõ°²¶¨Ð§¹û×îºÃ£¬ÁªºÏÓÃÒ©½Ïµ¥Ò»Ð§¹ûÒªºÃ£¬ÈçÂÈÏõ°²¶¨ºÍ±ûÎìËáÄÆ»òÆËðïͪµÈÁªºÏÓÃÒ©£¬ÑÏÖØ²¡ÈËÉõÖÁ¿ÉÒÔ3ÖÖÒ©ÎïÁªºÏʹÓ᣶ÔСÄÔÐÔ¹²¼Ãʧµ÷ÉÐÎÞ¶ÔÖ¢ÖÎÁƵĴëÊ©£¬ÎïÀíÁÆ·¨ºÍ¿µ¸´ÑµÁ·Ò²ºÜÖØÒª¡£±¾²¡½øÕ¹»ºÂý£¬²»Ó°ÏìÊÙÃü£¬²¡³Ì¿É³ÖÐøÊý10ÄêÖ®¾Ã¡£

    °Ë¡¢ÎÊÌâ¼°Õ¹Íû

    ËäÈ»¶ÔRHSµÄÈÏʶÒÑÓÐ70¶àÄêµÄÀúÊ·£¬µ«ÊÇĿǰ¶Ô±¾²¡µÄÈÏʶ»¹±È½Ï·ôdz£¬»¹´æÔÚһЩÎÊÌâÖµµÃ½øÒ»²½Ì½ÌÖ£º(1)RHSÕâÒ»Ãû³Æ²¢Î´±»ÆÕ±éÈϿɣ¬ÆäÇ¡µ±µÄÃüÃû¡¢·ÖÀ༰ÓëÆäËûÁÙ´²±íÏÖÀàËÆµÄ¼²²¡Ïà¼ø±ðÉÏ»¹´æÔÚÐí¶àÎÊÌâ;(2)¼¡ÕóÂÎÐÔñ²ðïºÍСÄÔÐÔ¹²¼Ãʧµ÷µÄ¹ØÏµ¼°Æä½âÆÊºÍ²¡ÀíÉúÀíѧ»úÖÆÉв»Çå³þ;(3)Ô˶¯ÐÔ¼¡ÕóÂεĴæÔÚʹÈËÃǺÜÄÑÆÀ¼ÛСÄÔ¹¦ÄÜ;(4)Ô­·¢ÐÔñ²ðïºÍ¼¡ÕóÂεIJ¡È˶àÄêºó³öÏÖ¹²¼Ãʧµ÷£¬ÊÇ·ñÓ뿹ñ²ðïÒ©ÓйØ;(5)Çø·Ö¼¡ÕóÂκͷÇñ²ðïÐÔÉúÀíÐÔ¼¡ÕóÂδÓÁÙ´²ºÍµçÉúÀíÉÏÊÇÊ®·ÖÀ§ÄѵÄ;(6)RHSÓëPMEÖ®¼äµÄ¹ØÏµºÜ»ìÂÒ£¬ËüÃǼȲ»ÄÜÍêÈ«µÈͬ£¬µ«ÓÖÓÐÖØµþ¡£

    ÖµµÃ̽ÌÖµÄÎÊÌâÊÇΪʲô¼¡ÕóÂΡ¢Ð¡ÄÔÐÔ¹²¼Ãʧµ÷¡¢ñ²ðï°éÓлò²»°éÓÐÖÇÄÜÕϰ­Õâ×éÁÙ´²Ö¢×´ÏàËÆµÄ¼²²¡£¬ÆäÉú»¯¡¢²¡Àí¼°ÒÅ´«Ñ§»ù´¡È´²»Í¬£¬¼¡ÕóÂκÍСÄÔÐÔ¹²¼Ãʧµ÷ͬʱ³öÏֵĽâÆÊѧ»ù´¡¼°³Ý×´ºË²¡±äµÄ֢״ѧÒâÒåºÎÔÚ¡£

    ×÷Õßµ¥Î»: 100053 ±±¾©£¬Ê×¶¼Ò½¿Æ´óѧÐûÎäÒ½ÔºÉñ¾­ÄÚ¿Æ

    ²Î¿¼ÎÄÏ×

    1 Hunt JR. Dyssynergia cerebellaris myoclonica-primary atrophy of the dentate system : a contribution to the pathology and symptomatology of the cerebellum. Brain, 1921£¬ 44: 490-538.

    2 Shakir RA,Khan RA, al-Zuhair AG. Progressive myoclonic ataxia without ragged red fibres:Unverricht-Lundborg disease vs Ramsay Hunt syndrome. Acta Neurol Scand, 1992£¬86:470-473.

    3 Berkovic SF, Andermann F. Ramsay Hunt syndrome: to bury or to praise. J Neurol Neurosurg Psychiatry, 1990, 53: 89-90.

    4 Tassinari CA,Michelucci R,Genton P,et al. Dyssynergia cerebellaris myoclonica (Ramsay Hunt syndrome): a condition unrelated to mitochondrial encephalomyopathies. J Neurol Neurosurg Psychiatry, 1989,52:262-265.

    5 Marsden CD,Harding AE,Obeso JA, et al. Progressive myoclonic ataxia (the Ramsay Hunt syndrome). Arch Neurol,1990,47:1121-1125.

    6 Classification of progressive myoclonus epilepsies and related disorder. Ann Neurol, 1990, 28:113-116.

    7 Kobayashi K, Morikawa K, Fukutani Y,et al. Ramsay Hunt syndrome: progressive mental deterioration in association with unusual cerebral white matter change. Clin Neuropathol£¬1994,13:88-96.

    8 Kunesch E,Becker WJ, Freund HJ. Myoclonus and sensorimotor integration in a patient with Ramsay Hunt syndrome. Electroencephalogr Clin Neurophysiol, 1991, 81:337-343.

    9 Berkovic SF,Andermann F,Carpenter S,et al. Progressive myoclonus epilepsies: specific causes and diagnosis. N Engl J Med, 1986,315:296-305.

    10 Oldfors A, Holme E, Tulinius M, et al. Tissue distribution and disease manifestations of the tRNA (Lys)A-G 8344 mitochondrial DNA mutation in a case of myoclonus epilepsy and ragged red fibres. Acta Neuropathol(Berl)£¬ 1995,90:328-333.

    11 Tassinari CA, Coccagna G, Mantovani M, et al. Polygraphic study of dyssynergia cerebellaris myoclonica (Ramsay Hunt syndrome) and the intention myoclonus (Lance-Adams syndrome) during sleep. Eur Neurol£¬ 1973, 9: 105-120.

    12 Obeso JA,Artieda J,Rothwell JC, et al. The treatment of severe action myoclonus. Brain, 1989, 112: 765-777.

    À´Ô´:ÖлªÉñ¾­¿ÆÔÓÖ¾1999ÄêµÚ1ÆÚ ×÷Õß:Õ²ÊçÇÙ ÍõÏò²¨ ÍõÓµ¾ü
Ïà¹ØÎÊ´ð£º
  • ñ²ðï(¼¡ÕóÂÎʧÉñ)
  • ñ²ðïʧÉñÐÔ¼¡ÕóÂÎÔõôÖÎÁÆ
  • ˯ǰ¼¡ÕóÂÎÓëñ²ðïÓйØÂð£¿
  • ÒòÄÔ²¿ÊܹýÉ˾­³£¼¡ÕóÂη¢×÷
  • Ò¹¼ä¼¡ÕóÂÎÊÇʲô²¡£¬ÈçºÎÖÎÁÆ
  • ʲôÊÇ·Çñ²ðïÐÔ¼¡ÕóÂÎ?ÓÐʲôºÃ°ì·¨ÖÎÁÆ?
  • ʲôÊÇ·Çñ²ðïÐÔ¼¡ÕóÂΣ¿ÓÐʲôºÃ·½·¨ÖÎÁÆ£¿.
  • ÈéËá¾úϸ¾úËØµÄ·Ö×ÓÉúÎïѧÑо¿½øÕ¹
  • ¶¬Áè²Ý¿ÆÑ§Ñо¿»ñÖØ´ó½øÕ¹
  • СÄÔ¹£Èû²»ÄÜÍÌÑÊÄܲ»ÄÜÖκÃ

  • Ïà¹Ø×ÊѶ£º
  • ñ²ðﲡµÄÈ«ÉíÕóÂÎÐÔ·¢×÷
  • ñ²ðïÈ«ÉíǿֱÕóÂÎÐÔ·¢×÷
  • ñ²ðﲡµÄÈ«ÉíÕóÂÎÐÔ·¢×÷
  • ñ²ðïÈ«ÉíǿֱÕóÂÎÐÔ·¢×÷
  • ñ²ðﲡµÄÈ«ÉíÕóÂÎÐÔ·¢×÷
  • ñ²ðïÈ«ÉíǿֱÕóÂÎÐÔ·¢×÷
  • £¨ÌìÂ×¼ÒÔ°£©Ñо¿½øÕ¹
  • ÖÎÁÆÂýÐÔÆ£ÀÍÑо¿½øÕ¹
  • Õë¾ÄÖÎÑôðôµÄÑо¿½øÕ¹
  • ÑôðôÑо¿µÄÏÖ×´Óë½øÕ¹ÈçºÎ
  • ½¡¿µÍ¼Æ×
    ½¡¿µÉ̳Çhttp://shop.xywy.com ½¡¿µ¹ºÎïºÃÈ¥´¦
    ÓÑÇéÁ´½Ó